Apple has launched the Apple Health AI Usage Study in the United States, a virtual research study and an associated app “designed to advance the understanding of how people interact with conversational health AI tools.” In a 15 November newsroom post, the company said the work is conducted in collaboration with OpenEvidence and “aims to inform the responsible design of health AI experiences for Apple and the industry.”
The study is open to up to 200,000 eligible participants aged 21 and older in the United States. To join, they must have an Apple Intelligence-enabled iPhone (iPhone 15 Pro or later) running iOS 26 or later. The App Store listing for the Apple Health AI Study App, sold by Apple Inc., says the app requires iOS 26.0 or later, is 29.9 MB, and is rated 18+. Enrollment is through the study app, not through a change to the everyday Health app.
This sits on TSN’s Tech for Good beat as a piece of health-AI research, not as a new clinical product.
The study will look at trust, comprehension and everyday use
Apple said the study will examine “what drives user trust, the quality of responses, comprehension, and everyday health actions.” In the app, participants can ask everyday health questions, read medical information “communicated with approachable language,” and see “linked, peer-reviewed clinical citations that ground each response.” They may also choose to share HealthKit data types, “such as resting heart rate, activity, sleep, or lab results,” to see how personal data changes relevance and understanding. Sharing those metrics, and any survey responses, is optional.
OpenEvidence is described by Apple as a clinical AI platform used by healthcare professionals, drawing on medical information from sources such as The New England Journal of Medicine, the Journal of the American Medical Association and Nature. The study, Apple said, “brings together medically grounded AI technology developed by OpenEvidence with an Apple-designed research experience.”
Sumbul Desai, M.D., Apple’s vice president of Health and Fitness, said: “Health is deeply personal, and conducting a dedicated research study is the most thoughtful way to understand how people engage with, comprehend, and evaluate health AI in everyday life.” Robert M. Wachter, M.D., professor and chair of the Department of Medicine at UCSF, said: “Patients and clinicians are both turning to AI, but the tools they use are being built and tested in separate worlds.”
Apple said “study data will not be used to train AI models,” and that the app has “safety guardrails that are intended to detect certain concerning questions and suggest that a participant follow up with a provider or other resources if needed.” A footnote to the newsroom post states: “The study app is not meant to diagnose or treat any condition, or replace the advice of medical professionals.” The App Store description says the same in plainer terms: “Neither the app nor the research study provides medical advice, diagnosis, or treatment.”
Two details circulating in the press are not in that newsroom post. Fierce Healthcare reported that participants may remain in the study for up to 12 months. TechCrunch reported that OpenEvidence deletes the query and response data after 24 hours. Those are the outlets’ accounts, not statements on Apple’s own page.
The Apple Health AI Study is research, not a diagnostic clearance
The easiest mistake is to read a 200,000-person health app as a product launch. Apple has opened a study and a study app. It has not said that a conversational health assistant is coming to the Health app or to Siri, and the official pages are explicit that the app is not meant to diagnose or treat anyone. That is a different kind of fact from an FDA clearance for an MRI-based tool that scores breast-cancer recurrence risk, which TSN has already covered as a regulated device claim. The Usage Study does not sit in that category.
It also does not, by itself, answer the clinical questions that other healthcare-AI work tries to measure. A UCL study TSN recorded on AI heart-MRI readings was about whether a model predicted survival slightly better than experts. Apple’s design is about trust, comprehension and everyday actions among people who already have a recent iPhone. Even if the enrollment cap is filled, that is a usage study in one country, on one hardware range, with optional HealthKit sharing. It is not a trial of a treatment.
The UK has no access path in the announcement. Eligible participants have to be in the United States. The useful UK comparison on TSN is UKRI’s funding of five healthcare-AI research hubs, a public research programme rather than a consumer study app. Those are parallel efforts, not a UK edition of this study.
The press-only duration and deletion claims should be kept in that box until Apple or OpenEvidence puts them on an official page. Until then, the record from Apple is the enrollment cap, the device requirement, the optional HealthKit sharing, the promise that study data will not be used to train models, and the clear limit that the app is not a diagnostic tool. The next facts worth watching are ordinary ones: whether Apple publishes results from the study, and whether anything from it later appears as a shipping health feature.
Sources
- Apple, “Apple launches research study to explore the use of AI for health,” 15 November 2026
- App Store, Apple Health AI Study App, seller Apple Inc.
- Heather Landi, “HLTH26: Apple kicks off 200K-person health AI study,” Fierce Healthcare, 15 November 2026
- Ivan Mehta, “Apple launches new app to study how people use AI for health,” TechCrunch, 15 November 2026
Get TSN’s biggest tech stories, explained.
News and insights across AI, tech, crypto and cybersecurity. Every source linked. Unsubscribe anytime.
Get the newsletterRelated stories
- UKRI Funds Five Healthcare AI Research Hubs Over £52m is the nearest TSN account of publicly funded healthcare-AI research, and the right contrast with a US-only consumer study app.
- AI Heart MRI Readings Predict Survival Slightly Better Than Experts
- FDA Clears MRI-Based AI That Scores 10-Year Breast Cancer Return Risk
Follow @tsnmediahub on X for breaking AI news as it happens.
Follow on X

